Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
Clinical trial NCT00390312 · COMPLETED
Trial details
- NCT number
- NCT00390312
- Sponsor
- Javelin Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2001-11-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.